Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.51 |
| ▸ | LMNA | P02545 | 5/20 | 0.51 |
| ▸ | MEN1 | O00255 | 4/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.51 |
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.41 |
| ▸ | WNT3A | P56704 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18155097 | 0.84 | ALDH1A1 (0.53) | ALDH1A1LMNAMEN1KMT2ATSHR | |
| SCHEMBL16654050 | 0.74 | LMNA (0.49) | ALDH1A1LMNAMEN1KMT2ATSHR | |
| SCHEMBL5312985 | 0.66 | S1PR1 (0.70) | MEN1KMT2ANPC1RAB9A | |
| SCHEMBL12433080 | 0.66 | RAB9A (0.57) | ALDH1A1LMNAMEN1KMT2ATSHR | |
| SCHEMBL9960053 | 0.65 | SMN1; SMN2 (0.46) | ALDH1A1LMNAMEN1KMT2ATSHR | |
| SCHEMBL9960048 | 0.65 | SMN1; SMN2 (0.46) | ALDH1A1LMNAMEN1KMT2ATSHR | |
| SCHEMBL2751428 | 0.64 | TSHR (0.48) | ALDH1A1LMNATSHRNPSR1HTT | |
| SCHEMBL29068563 | 0.64 | RAB9A (0.57) | ALDH1A1LMNAMEN1KMT2ATSHR | |
| SCHEMBL202308 | 0.64 | RAB9A (0.57) | ALDH1A1LMNAMEN1KMT2ATSHR | |
| SCHEMBL15426186 | 0.63 | LMNA (0.64) | ALDH1A1LMNAMEN1KMT2ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180086735-A1 | N-CYCLOALKYL-N-(BIHETEROCYCLYETHYLENE)-(THIO)CARBOXAMIDE DERIVATIVES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2018-03-29 | — | — | US | disclosed |
| EP-3283476-A1 | N-CYCLOALKYL-N-(BIHETEROCYCLYETHYLENE)-(THIO)CARBOXAMIDE DERIVATIVES | Bayer Cropscience AG (DE) | 2018-02-21 | — | — | EP | disclosed |
| WO-2016166077-A1 | N-CYCLOALKYL-N-(BIHETEROCYCLYETHYLENE)-(THIO)CARBOXAMIDE DERIVATIVES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2016-10-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180086735-A1 | N-CYCLOALKYL-N-(BIHETEROCYCLYETHYLENE)-(THIO)CARBOXAMIDE DERIVATIVES | CBR3, CYP51A1, CBR1 | ALDH1A1 3823/4885LMNA 2944/4885MEN1 4168/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.